Intralytix Inc. is a biotechnology company structured around acteriophage-based products used to control bacterial pathogens in environmental, food processing, and medical settings. Bacteriophages (bacteria-eater: from the Greek phago meaning "to eat" or "to develop at expense of") are the most abundant microorganisms on earth and are the natural enemies of bacteria. Lytic bacteriophages can very effectively kill their targeted specific bacteria without affecting anything else, ensuring an unprecedented level of safety for an antimicrobial. The firm offers various food safety products that target listeria monocytogenes, escherichia coli, and pathogenic salmonella-serotypes contaminations in foods and food processing facilities. The company also provides probiotic/nutraceutical products, including ShigActive, which targets shigella species in the gastrointestinal tract. In addition, Intralytix develops and licenses animal health products, including INT-401, which targets clostridium perfringens in live poultry; and PLSV-1 that provides protection for poultry against colonization pathogenic salmonella serotypes. Further, the company offers human health products that target staphylococcus aureus and acinetobacter baumannii.
